Glycemic control and extended hemodialysis survival in patients with diabetes mellitus: Comparative results of traditional and time-dependent cox model analyses

Clinical Journal of the American Society of Nephrology

Volumn 5, Issue 9, 2010, Pages 1595-1601

  Williams, Mark E ^a   Lacson Jr , Eduardo ^b   Wang, Weiling ^b   Lazarus, J Michael ^b   Hakim, Raymond ^b  

^a JOSLIN DIABETES CENTER   (United States)

^b FRESENIUS MEDICAL CARE NORTH AMERICA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; SERUM ALBUMIN;

ADULT; ARTICLE; COMPARATIVE STUDY; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL STATUS; OBSERVATIONAL STUDY; POST HOC ANALYSIS; PROPORTIONAL HAZARDS MODEL; RISK; SURVIVAL;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CHI-SQUARE DISTRIBUTION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NORTH AMERICA; NUTRITIONAL STATUS; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; SERUM ALBUMIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 77957315885     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.09301209     Document Type: Article

References (37)

1. Avendano M, Mackenbach JP: Blood glucose levels: Facing a global crisis. Lancet 368: 1631-1632, 2006 (Pubitemid 46048536)
2. Selvin E, Coresh J, Golden SH, Brancati FL, Folsom AR, Steffes MW: Glycemic control and coronary heart disease risk in persons with and without diabetes. The Atherosclerosis Risk in Communities Study. Arch Intern Med 165: 1910-1916, 2005
3. Home P: Contributions of basal and post-prandial hyperglycaemia to micro- and macrovascular complications in people with type 2 diabetes. Curr Med Res Opin 21: 889-898, 2005
4. Gerstein HC, Miller ME, Byington RP: Action to Control Cardiovascular Risk in Diabetes Study Group: Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358: 2545-2559, 2008
5. ADVANCE Collaborative Group: Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358: 2560-2572, 2008 (Pubitemid 351831357)
6. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve F, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD, for the VADT Investigators: Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 360: 129-139, 2009
7. Skyler JS, Bergenstal R, Bonow RO: Intensive glycemic control and the prevention of cardiovascular events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association. J Am Coll Cardiol 53: 298-304, 2009
8. U.S. Renal Data System: USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2009
9. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus: The Diabetes Control and Complications Trial. N Engl J Med 329: 977-986, 1993
10. U.K. Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonyureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853, 1998
11. Feldt-Rasmussen B: Is there a need to optimize glycemic control in hemodialyzed diabetic patients? Kidney Int 70: 1392-1394, 2006 (Pubitemid 44527307)
12. K/DOQI: K/DOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis 49[Suppl 2]: S12-S154, 2007
13. Qaseem A, Vijan S, Snow V, Cross JT, Weiss KB, Owens DK: Glycemic control and type 2 diabetes mellitus: The optimal hemoglobin A1c targets. A guidance statement from the American College of Physicians. Ann Intern Med 147: 417-422, 2007 (Pubitemid 351664542)
14. Pogach LM, Brietzke SA, Cowan CL, Conlin P, Walder DJ, Sawin CT: Development of evidence-based clinical practice guidelines for diabetes. Diabetes Care 27[Suppl 2]: B82-B89, 2004
15. Williams ME, Lacson E Jr, Teng M, Ofsthun N, Lazarus JM: Hemodialyzed type I and II diabetic patients in the US: Characteristics, glycemic control, and survival. Kidney Int 70: 1503-1509, 2006 (Pubitemid 44527322)
16. Kalantar-Zadeh K, Kopple JD, Regidor DL, Jing J, Shinaberger CS, Aronovitz J, McAllister CJ, Whellan D, Sharma K: A1c and survival in maintenance hemodialysis patients. Diabetes Care 30: 1049-1055, 2007 (Pubitemid 46684623)
17. Cook CB, Hentz JG, Tsui C: Poor glycemic control increases the risk of hospitalization in urban African Americans with diabetes. Ethn Dis 16: 880-885, 2006
18. Amiel SA, Dixon T, Mann R, Jameson K: Hypoglycaemia in type 2 diabetes. Diabetic Med 25: 245-254, 2008
19. Abaterusso C, Lupo A, Ortalda V, DeBiase V, Pani A, Muggeo M, Gambaro G: Treating elderly people with diabetes and states 3 and 4 chronic kidney disease. Clin J Am Soc Nephrol 3: 1185-1194, 2008
20. Huang ES, Zhang QI, Gandra N, Chin MH, Meltzer DO: The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: A decision analysis. Ann Intern Med 149: 11-19, 2008
21. Moen MF, Zhan M, Hsu VD, Walker LD, Einhorn LM, Seliger SL, Fink JC: Frequency of hypoglycemia and its significance in chronic kidney disease. Clin J Am Soc Nephrol 4: 1121-1127, 2009
22. Whitmer RA, Karter AJ, Yaffe K, Quesenberry CP Jr, Selby JV: Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 301: 1565-1572, 2009
23. American Diabetes Association: Standards of medical care in diabetes - 2009. Diabetes Care 32: S87-S94, 2009
24. Greenfield S, Billimek J, Pellegrini F, Franciosi M, deBerardis G, Nicolucci A, Kaplan S: Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: A cohort study. Ann Intern Med 151: 854-860, 2009
25. Morioka T, Emoto M, Tabata T, Shoji T, Tahara H: Glycemic control is a predictor of survival for diabetic patients on hemodialysis. Diabetes Care 24: 909-913, 2001 (Pubitemid 33636068)
26. Wu MS, Yu CC, Yang CW, Wu CH, Haung JY, Hong JJ, Fan Chiang CY, Huang CC, Leu ML: Poor pre-dialysis glycaemic control is a predictor of mortality in type II diabetic patients on maintenance haemodialysis. Nephrol Dial Transplant 12: 2105-2110, 1997
27. Oomichi T, Emoto M, Tabata T, Morioka T, Tsujimoto Y, Tahara H, Shoji T, Nishizawa Y: Impact of glycemic control on survival of diabetic patients on chronic regular hemodialysis: A 7-year observational study. Diabetes Care 29: 1496-1500, 2006 (Pubitemid 44127570)
28. Manske CL: Hyperglycemia and intensive glycemic control in diabetic patients with chronic renal disease. Am J Kidney Dis 32: S157-S171, 1998
29. Tzamaloukas AH, Murata GH, Zager PG: The relationship between glycemic control and morbidity and mortality for diabetics on dialysis. ASAIO 39: 880-885, 1993
30. Rohlfing CL, Wiedmeyer HM, Little RR: Defining the relationship between plasma glucose and HbA(1c): Analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. Diabetes Care 275-278, 2002
31. Williams ME, Lacson E Jr, Teng M, Hakim RM, Lazarus JM: Extremes of glycemic control (HbA1c) increase hospitalization risk in diabetic hemodialysis patients in the USA. Am J Nephrol 29: 54-61, 2009
32. Abe M, Matsumoto K: Glycated hemoglobin or glycated albumin for assessment of glycemic control in hemodialysis patients with diabetes? Nature Clin Pract Nephr 4: 482-483, 2008
33. Peacock TP, Shihabi K, Bleyer AJ, Dolbare EL, Byers JR, Knovich MA, Calles-Escandon J, Russell GB, Freedman BI: Comparison of glycated albumin and hemoglobin A1c levels in diabetic subjects on hemodialysis. Kidney Int 73: 1062-1068, 2007
34. Kovesdy CP, Sharma K, Kalantar-Zadeh K: Glycemic control in diabetic CKD patients: Where do we stand? Am J Kidney Dis 52: 766-777, 2008
35. Schopman JE, Geddes J, Frier BM: Prevalence of impaired awareness of hypoglycaemia and frequency of hypoglycaemia in insulin-treated type 2 diabetes. Diabetes Res Clin Pract 87: 64-68, 2010
36. Redelmeier DA, Kenshole AB, Ray JG: Motor vehicle crashes in diabetic patients with tight glycemic control: A population-based case control analysis. PLoSMed 2009 6: e1000192
37. Williams ME, Lacson E Jr, Wang W, Lazarus JM, Hakim R: High glucose variability increases risk of all-cause and hypoglycemia-related hospitalization in diabetic chronic hemodialysis patients [Abstract]. J Am Soc Nephrol 20: 193A, 2009